“In vivo validation of late-onset Alzheimer’s disease genetic risk factors.” Michael Sasner, et al. – The Jackson Laboratory. Background:...
Alzheimer’s Disease
“Identification of Rare Damaging Missense and Loss of Function Variants in GWAS Loci Using Genome Sequencing Data from Two...
“Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer’s disease.” David Berron, et al. –...
“Psychotic symptoms are associated with elevated tau PET signal in the amygdala independent of Alzheimer’s disease clinical severity and...
“Somatic cancer driver mutations are enriched and associated with inflammatory states in Alzheimer’s disease microglia.” August Yue Huang, et...
“Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer’s disease.” Prabesh Bhattarai, et al. – Columbia...
“Noradrenergic signaling controls Alzheimer’s disease pathology via activation of microglial β2 adrenergic receptors.” Linh Le, et al. – University...
“P-tau217 and other blood biomarkers of dementia: variation with time of day.” Ciro della Monica, et al. – University...
“Validation of remote collection and quantification of blood Neurofilament light in neurological diseases.” Annabelle Coleman, et al. – University...
“Medial temporal lobe hyperconnectivity is key to Alzheimer’s disease: Insight from physiological aging to dementia.” Léa Chauveau, et al....